β− Arrestins: structure, function, physiology, and pharmacological perspectives

J Wess, AB Oteng, O Rivera-Gonzalez… - Pharmacological …, 2023 - ASPET
The two β-arrestins, β-arrestin-1 and-2 (systematic names: arrestin-2 and-3, respectively),
are multifunctional intracellular proteins that regulate the activity of a very large number of …

Genomic profiling for clinical decision making in lymphoid neoplasms

L De Leval, AA Alizadeh, PL Bergsagel… - Blood, The Journal …, 2022 - ashpublications.org
With the introduction of large-scale molecular profiling methods and high-throughput
sequencing technologies, the genomic features of most lymphoid neoplasms have been …

[HTML][HTML] Not all LGL leukemias are created equal

G Semenzato, G Calabretto, G Barilà, VR Gasparini… - Blood Reviews, 2023 - Elsevier
Abstract Large Granular Lymphocyte (LGL) Leukemia is a rare, heterogeneous even more
that once thought, chronic lymphoproliferative disorder characterized by the clonal …

KLRG1 cell depletion as a novel therapeutic strategy in patients with mature T-cell lymphoma subtypes

B Assatova, R Willim, C Trevisani, G Haskett… - Clinical Cancer …, 2024 - AACR
Purpose: Develop a novel therapeutic strategy for patients with subtypes of mature T-cell
and NK-cell neoplasms. Experimental Design: Primary specimens, cell lines, patient-derived …

Analysis of somatic mutations in whole blood from 200,618 individuals identifies pervasive positive selection and novel drivers of clonal hematopoiesis

N Bernstein, M Spencer Chapman, K Nyamondo… - Nature Genetics, 2024 - nature.com
Human aging is marked by the emergence of a tapestry of clonal expansions in dividing
tissues, particularly evident in blood as clonal hematopoiesis (CH). CH, linked to cancer risk …

Large granular lymphocyte leukemia: An indolent clonal proliferative disease associated with an array of various immunologic disorders

G Drillet, C Pastoret, A Moignet, T Lamy… - La Revue de Médecine …, 2023 - Elsevier
Large granular lymphocyte leukemia (LGLL) is a chronic lymphoproliferative disorder
characterized by the proliferation of T or NK cytotoxic cells in the peripheral blood, the …

The complex relationship between large granular lymphocyte leukemia and rheumatic disease

T Marchand, T Lamy - Expert Review of Clinical Immunology, 2024 - Taylor & Francis
Introduction Large granular lymphocytic (LGL) leukemia is a rare lymphoproliferative
disorder characterized by an expansion of clonal T or NK lymphocytes. Neutropenia-related …

A lineage-specific STAT5BN642H mouse model to study NK-cell leukemia

K Klein, S Kollmann, A Hiesinger, J List, J Kendler… - Blood, 2024 - ashpublications.org
Patients with T-and natural killer (NK)-cell neoplasms frequently have somatic STAT5B gain-
of-function mutations. The most frequent STAT5B mutation is STAT5B N642H, which is …

[HTML][HTML] GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis

J Xiong, YT Dai, WF Wang, H Zhang, CF Wang, T Yin… - Science Bulletin, 2023 - Elsevier
Epstein-Barr virus (EBV) is the oncogenic driver of multiple cancers. However, the
underlying mechanism of virus-cancer immunological interaction during disease …

LGL clonal expansion and unexplained cytopenia: two clues don't make an evidence

G Calabretto, E Attardi, C Gurnari, G Semenzato… - Cancers, 2022 - mdpi.com
Simple Summary The clonal expansions of large granular lymphocytes are frequently
detected in a wide spectrum of hematological and immune diseases. This clinical overlap …